Sita Tablet 25 mg (Sitagliptin Phosphate Hydrate)
Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
MFDS item code 201504253 · Approved 2015.06.30
This product's status changed to Approval withdrawn on 2024.12.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood sugar control in type 2 diabetes
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It is administered alone to patients who have not previously received diabetes treatment, and it is used in combination with metformin when blood sugar control is difficult with monotherapy. Furthermore, it is used in combination when blood sugar control is insufficient with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin. If blood sugar control remains difficult even with multiple medications, this medication is additionally administered to improve blood sugar levels. Depending on the patient's condition, it can be used alone or in combination therapy, playing an important role in effective blood sugar management and diabetes treatment.
This medication is administered once daily at a dose of 100 mg, with a maximum recommended dose of 100 mg per day. It can be taken regardless of meals. Dosage adjustment is needed based on kidney function. - Mild renal impairment (eGFR 60–90 mL/min/1.73 m2): No dosage adjustment needed. - Moderate renal impairment (eGFR 45–60 mL/min/1.73 m2):
This medication is used for the treatment of diabetes and helps to control blood sugar levels. Rarely, severe allergic reactions may occur during treatment with this medication, so if symptoms such as skin rash, breathing difficulties, or swelling of the face or neck appear, you should immediately stop taking the medication and consult your healthcare provider. Additionally, this medication can cause pancreatitis, a condition that involves inflammation of the pancreas, so you should inform your healthcare provider immediately if you experience severe abdominal pain, nausea, or vomiting. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and those who are hypersensitive to this medication or its components should also avoid it. Patients with impaired kidney function should have their dosage adjusted and administered with caution, and attention is needed for potential allergic reactions to the dye included in this medication. While taking this medication, hypoglycemia may occur, especially when taken with insulin or sulfonylureas, which can increase the risk of hypoglycemia. If severe joint pain or skin blistering symptoms occur, you should immediately consult your doctor to determine whether to discontinue the medication. Women who are pregnant or breastfeeding are advised against using this medication as its safety has not been established, and its safety and efficacy have not been confirmed in children and adolescents under 18 years of age. In elderly patients, renal function may decline, so it is advisable to monitor kidney function regularly before and after taking this medication. In cases of overdose, general symptomatic treatment should be performed, and if necessary, some of the drug may be removed by hemodialysis. This medication tends to have fewer interactions with other medications, but caution is necessary when used in combination with certain drugs, so it is advisable to consult a doctor or pharmacist. If any abnormal symptoms occur while taking this medication, it is essential to consult your healthcare provider for appropriate actions.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way can help maintain the medication's efficacy for a long time.
Pink, round, biconvex, film-coated tablet
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Jong Kundang Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Sinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.